Meyer Handelman Company’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $261K | Buy |
+675
| New | +$250K | 0.01% | 224 |
|
|
2026
Q1 | – | Sell |
-700
| Closed | -$245K | – | 225 |
|
|
2025
Q4 | $245K | Hold |
700
| – | – | 0.01% | 203 |
|
|
2025
Q3 | $226K | Hold |
700
| – | – | 0.01% | 207 |
|
|
2025
Q2 | $272K | Hold |
700
| – | – | 0.01% | 199 |
|
|
2025
Q1 | $304K | Hold |
700
| – | – | 0.01% | 189 |
|
|
2024
Q4 | $258K | Hold |
700
| – | – | 0.01% | 197 |
|
|
2024
Q3 | $364K | Hold |
700
| – | – | 0.01% | 186 |
|
|
2024
Q2 | $379K | Sell |
700
-100
| -13% | -$52.9K | 0.01% | 180 |
|
|
2024
Q1 | $415K | Hold |
800
| – | – | 0.01% | 179 |
|
|
2023
Q4 | $377K | Hold |
800
| – | – | 0.01% | 170 |
|
|
2023
Q3 | $348K | Hold |
800
| – | – | 0.01% | 174 |
|
|
2023
Q2 | $355K | Hold |
800
| – | – | 0.01% | 170 |
|
|
2023
Q1 | $368K | Hold |
800
| – | – | 0.02% | 168 |
|
|
2022
Q4 | $410K | Hold |
800
| – | – | 0.02% | 163 |
|
|
2022
Q3 | $363K | Hold |
800
| – | – | 0.02% | 167 |
|
|
2022
Q2 | $386K | Hold |
800
| – | – | 0.02% | 168 |
|
|
2022
Q1 | $393K | Hold |
800
| – | – | 0.02% | 169 |
|
|
2021
Q4 | $371K | Hold |
800
| – | – | 0.01% | 169 |
|
|
2021
Q3 | $298K | Hold |
800
| – | – | 0.01% | 185 |
|
|
2021
Q2 | $305K | Hold |
800
| – | – | 0.01% | 194 |
|
|
2021
Q1 | $287K | Hold |
800
| – | – | 0.01% | 191 |
|
|
2020
Q4 | $257K | Hold |
800
| – | – | 0.01% | 183 |
|
|
2020
Q3 | $215K | Sell |
800
-1,300
| -62% | -$350K | 0.01% | 178 |
|
|
2020
Q2 | $552K | Hold |
2,100
| – | – | 0.03% | 159 |
|
|
2020
Q1 | $477K | Hold |
2,100
| – | – | 0.03% | 151 |
|
|
2019
Q4 | $634K | Hold |
2,100
| – | – | 0.03% | 157 |
|
|
2019
Q3 | $504K | Hold |
2,100
| – | – | 0.03% | 162 |
|
|
2019
Q2 | $593K | Hold |
2,100
| – | – | 0.03% | 159 |
|
|
2019
Q1 | $622K | Hold |
2,100
| – | – | 0.03% | 153 |
|
|
2018
Q4 | $552K | Hold |
2,100
| – | – | 0.03% | 152 |
|
|
2018
Q3 | $576K | Hold |
2,100
| – | – | 0.03% | 158 |
|
|
2018
Q2 | $500K | Hold |
2,100
| – | – | 0.03% | 166 |
|
|
2018
Q1 | $461K | Hold |
2,100
| – | – | 0.02% | 166 |
|
|
2017
Q4 | $473K | Hold |
2,100
| – | – | 0.02% | 164 |
|
|
2017
Q3 | $399K | Hold |
2,100
| – | – | 0.02% | 169 |
|
|
2017
Q2 | $395K | Hold |
2,100
| – | – | 0.02% | 166 |
|
|
2017
Q1 | $347K | Hold |
2,100
| – | – | 0.01% | 167 |
|
|
2016
Q4 | $302K | Hold |
2,100
| – | – | 0.01% | 171 |
|
|
2016
Q3 | $263K | Hold |
2,100
| – | – | 0.01% | 175 |
|
|
2016
Q2 | $276K | Hold |
2,100
| – | – | 0.01% | 177 |
|
|
2016
Q1 | $292K | Hold |
2,100
| – | – | 0.01% | 182 |
|
|
2015
Q4 | $293K | Hold |
2,100
| – | – | 0.01% | 181 |
|
|
2015
Q3 | $294K | Hold |
2,100
| – | – | 0.01% | 180 |
|
|
2015
Q2 | $345K | Hold |
2,100
| – | – | 0.02% | 174 |
|
|
2015
Q1 | $324K | Hold |
2,100
| – | – | 0.01% | 178 |
|
|
2014
Q4 | $264K | Hold |
2,100
| – | – | 0.01% | 186 |
|
|
2014
Q3 | $251K | Hold |
2,100
| – | – | 0.01% | 179 |
|
|
2014
Q2 | $226K | Hold |
2,100
| – | – | 0.01% | 182 |
|
|
2014
Q1 | $209K | Buy |
+2,100
| New | +$190K | 0.01% | 184 |
|
Other funds holding ELV
Meyer Handelman Company's ELV Position: Q2 2026 in Review
Meyer Handelman Company opened a new position in Elevance Health (ELV) in Q2 2026: 675 shares worth $261K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings. This is a return to the name: Meyer Handelman Company previously reported a position in ELV as recently as Q4 2025.
Meyer Handelman Company first reported a position in ELV in Q1 2014 and has held it in 49 quarters since. The position peaked at $634K in Q4 2019. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Meyer Handelman Company held 675 shares of Elevance Health worth $261K as of Q2 2026.
- Elevance Health was a new Meyer Handelman Company position in Q2 2026.
- Elevance Health made up 0.01% of Meyer Handelman Company's portfolio in Q2 2026, its #224 holding.
- Meyer Handelman Company first reported a position in Elevance Health in Q1 2014 and has held it in 49 quarters since.
- Meyer Handelman Company's Elevance Health position peaked at $634K in Q4 2019.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.